New Rochelle, NY, July 14, 2015--Medical evidence supports the potential for acupuncture to be significantly more effective in the treatment of dermatologic conditions such as dermatitis, pruritus, and urticaria than alternative treatment options, "placebo acupuncture," or no treatment, according to a review of the medical literature published in the Journal of Alternative and Complementary Medicine, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers. The review article is available free on the Journal of Alternative and Complementary Medicine website until August 14, 2015.
In "Acupuncture as a Treatment Modality in Dermatology: A Systematic Review," authors Chelsea Ma, MD, and Raja Sivamani, MD, MS, CAT, University of California, Davis, analyzed the findings from 24 studies in which acupuncture was used as a primary treatment method for a range of dermatologic disorders. The data support statistically significant improvement in patient outcomes in several conditions, including when acupuncture was compared to placebo acupuncture, in which needles or pressure are applied but not at the specific sites associated with a therapeutic effect.
About the Journal
The Journal of Alternative and Complementary Medicine is a monthly peer-reviewed journal published online with open access options and in print. The Journal provides observational, clinical, and scientific reports and commentary intended to help healthcare professionals and scientists evaluate and integrate therapies into patient care protocols and research strategies. Complete tables of content and a sample issue may be viewed on the Journal of Alternative and Complementary Medicine website.
About the Publisher
Mary Ann Liebert, Inc., publishers is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including Alternative and Complementary Therapies, Medical Acupuncture, and Journal of Medicinal Food. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's 80 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc., publishers (http://www.